East Tennessee State University

Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations

Student Works

May 1982

Tonsil Cell Products which Modify in Vitro
Proliferation of Blood Lymphocytes
Thomas W. Hodge
East Tennessee State University

Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Immunology and Infectious Disease Commons
Recommended Citation
Hodge, Thomas W., "Tonsil Cell Products which Modify in Vitro Proliferation of Blood Lymphocytes" (1982). Electronic Theses and
Dissertations. Paper 2731. https://dc.etsu.edu/etd/2731

This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.

IN F O R M A T IO N TO USERS

This was produced from a copy o f a document sent to us fo r microfilming. White the
most advanced technological means to photograph and reproduce this document
have been used, the quality is heavily dependent upon the quality o f the material
submitted.
The following explanation o f techniques is provided to help you understand
markings or notations which may appear on this reproduction.
1 .T h e sign or "target" fo r pages apparently lacking from the document
photographed is "Missing Page(s)". If It was possible to obtain the missing
page(s) or section, they are spliced Into the film along with adjacent pages.
This may have necessitated cutting through an Image and duplicating
adjacent pages to assure you o f complete continuity.
2. When an image on the film Is obliterated with a round black mark it is an
indication that the film Inspector noticed either blurred copy because o f
movement during exposure, or duplicate copy. Unless we meant to delete
copyrighted materials that should not have been filmed, you will find a good
image o f the page in the adjacent frame. If copyrighted materials were
deleted you will find a target note listing the pages in the adjacent frame.
3. When a map, drawing or chart, etc., is part o f the material being photo*
graphed the photographer has followed a definite method in "sectioning"
the material. I t Is customary to begin film ing at the upper left hand corner o f
a large sheet and to continue from left to right in equal sections with small
overlaps. I f necessary, sectioning is continued again—beginning below the
first row and continuing on until complete.
4. For any illustrations that cannot be reproduced satisfactorily by xerography,
photographic prints can be purchased at additional cost and tipped into your
xerographic copy. Requests can be made to our Dissertations Customer
Services Department.
5. Some pages in any document may have indistinct print, tn all cases we have
film ed the best available copy.

UniversiV

Mfcrdfilms
International

300 N. ZEEB RD.. ANN ARBOR. Ml 4B106

8216621

Hodge, Thomas Weston

T O N S IL C E L L PRO DUCTS W H IC H M O D IF Y IN V ITR O P R O LIFE R A TIO N
O F BLO O D LYM PH O C YTES

East Tennessee State University

University
Microfilms
International

300 N. Zeeb Road, Ann Arbor, M I 48106

Ph.D .

1982

PLEASE NOTE:

tn all cases this material has been filmed In the best possible way from the available copy.
Problems encountered with this document have been identified here with a check mark V

.

1.

Glossy photog raphs or pages

1/

2.

Colored illustrations, paper or print______

3.

Photog raphs with dark background

4.

Illustrations are poor copy ^

5.

Pages with black marks, not original copy______

6.

Print shows through as there is text on both sides of page______

7.

Indistinct, broken or small print on several pages.______

8.

Print exceeds margin requirements______

9.

Tightly bound copy with print lost in spine______

10.

Computer printout pages with indistinct print______

11.

Page(s)____________ lacking when material received, and not available from school or
author.

12.

Page(8)____________ seem to be missing in numbering only as text follows.

13.

Two pages numbered___________ . Text follows.

14.

Curling and wrinkled p ag es______

15.

Other_________________________________________________________________ _

^

_

University
Microfilms

International

TONSIL CELL PRODUCTS WHICH MODIFY IN VITRO
PROLIFERATION OF BLOOD LYMPHOCYTES

A Dissertation
Presented to
the Faculty of the Department of Biochemistry
Quillen-Dishner College of Medicine
East Tennessee State University

In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy in Biomedical Sciences

by
Thomas Weston Hodge
May, 1982

DISSERTATION APPROVAL
THOMAS WESTON HODGE

Tonsil Cell Products Which Modify In Vitro
Proliferation of Blood Lymphocytes

This is to certify that the Graduate Committee of Thomas Weston
Hodge has reviewed and evaluated his dissertation and conducted his
defense of it in an open oral examination.

The committee recommends

to the Graduate Council and the Dean of the School of Graduate
Studies acceptance of the dissertation in partial fulfillment of the
requirements for the degree Doctor of Philosophy in Biomedical
Science

April 22, 1982
Chairman, Graduate Committee

ft/i

Signed on behalf of the
Graduate Council
DefcftTof Graduate Studies

ii

Abstract
TONSIL CELL PRODUCTS WHICH MODIFY IN VITRO
PROLIFERATION OF BLOOD LYMPHOCYTES
by
Thomas Weston Hodge

Human palatine tonsil lymphocytes, when compared to peripheral
blood lymphocytes (PBL), were In an activated state even though there
was no in vitro stimulation• When these tonsil lymphocytes were
cultured In the absence of serum and polyclonal mitogens or antigens,
the supernatant fluid often inhibited the proliferative response of
target PBL to con A. The extent of this suppression ranged from 22%
to 84%, and target cell viability was 90% or greater. There was no
evidence for the presence of immunoglobulins or a2-macroglobulln in
whole supernatant fluids. The suppressor was partially denatured at
80° C and was rendered completely inactive upon exposure to 100° C
for 5 rain. It was trypsin sensitive, and had an apparent molecular
weight of 100,000 or greater. The protein adhered strongly to DE-52
cellulose, and the most active material eluted with 0.4-0.6 M NaCl.
The suppressor was active In the pH range 5.0 ± 0.6 as demonstrated
by Isoelectric focusing.
Occasionally, supernatant fluids comprised material which
augmented the expected response of con A stimulated PBL. The
augmentor was 30,000 in molecular weight and was eluted from DE-52
cellulose in the 0.15-0.25 M NaCl range.
Nearly all supernatant preparations tested contained a mltogenlc
substance which stimulated naive allogeneic human PBL without the
necessity of co-stlmulatlon by a mitogen. The mltogenlc factor (MF)
behaved In a dose dependent fashion and was evidently different from
the augmentor since the MF stimulated PBL independently of lectin costimulation.
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CHAPTER 1
INTRODUCTION
In recent times there has been exponential growth in the under
standing of the mechanisms of the Immune response.

One aspect of

Immunity which has gained particular attention is the area of
lymphoklne (1) research.
Lymphokines are soluble mediators which can be generated with
antigens or mitogens, either in vivo or in vitro.

They are produced by

normal thymus-derived T lymphocytes or bursal-equivalent lymphocytes
and by transformed T cell lines.

They function by suppressing or

helping immune responses, and they may or may not possess antigenic
determinants encoded by the major histocompatibility complex.
Lymphokines affect a wide variety of cell types in vitro including
lymphocytes, macrophages, neutrophils, basophils, eosinophils,
polymorphonuclear leukocytes, thymocytes, bone marrow cells, fibro
blasts, lymphoid cell lines, osteoclasts, and endothelial cells.

In

vivo, the role of lymphokines remains unclear, but they are assumed
to be involved in delayed type hypersensitivity, particularly in the
reticuloendothelial system, in the circulation, and at mucosal sites.
Presently there are 90 such lymphokines which have been identified
according to function and shown to have distinct molecular character
istics apart from immunoglobulins.

All lymphokines appear to be pro

teins or glycoproteins of a molecular weight greater than 10,000.
They behave similarly to glycoprotein hormones in that they both affect
distal targets and are recognized by specific membrane receptors.
Lymphokines may function as monomeric subunits, polymerize to
larger molecular weight forms, or non-specifically aggregate in the
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presence or absence of serum components (115). They may also be trans
ported by larger molecular weight proteins such as a 2-macroglobulin (32).
Prior to the advent of monoclonal antibodies, it was difficult
to develop strictly specific antibodies to lymphokines due to the lack
of substantial amounts of purified material.

However, hybridoma

technology has been Instrumental in producing antibodies specific for
certain lymphokines because this technique requires only partially
purified material.

It is reasonable then to assume that further ex

ploitation of hybridoma monoclonal antibodies will facilitate purifi
cation and biochemical characterization of the various lymphokines.
A comprehensive review of all the lymphokines is a somewhat
daunting task and is beyond the scope of this dissertation.

Instead,

the reader is referred to other sources for further discussion of this
expansive topic (2-6).

This literature review will focus primarily on

selected factors which are found in the human and pertinent to the
work described herein.
The existence of mltogenlc factor in humans was first noted by
Kaskura and Lowenstein (7) in the supernatant fluids of mixed leuko
cyte cultures.

Using peripheral blood from allogeneic donors, cells

were mixed and Incubated.

The supernatant fluids were added tonon-sensi-

tized cells which then were examined for blastogenesiB by their
ability to Incorporate radiolabelled thymidine.

Since then, mitogenic

factors have been redefined operationally as activities that appear
in supernatant fluids of leukocyte cultures and cause lymphocytes to
divide and/or synerglstlcally augment cell division Induced by other
lymphocyte stimulants.
Mltogenlc factors potentially may be produced by one or more

cell types In leukocyte cultures, e.g. lymphocytes, monocytes, and
neutrophils.

The present discussion will concern human lymphocyte

mltogenlc factor (HLMF) and T cell growth factor (TCGF), which are
T cell products, and lymphocyte activating factor (LAF) which Is a
product of macrophages.
A number of Investigators, using a variety of antigens and
mitogens as stimulatory agents, have successfully Implicated a subpopulation of thymus-derived cells which, during activated conditions,
produce human lymphocyte mltogenlc factor (8 , 9, 10).

Peripheral

lymphocytes from Mantoux positive individuals, were separated into
T and B cell populations according to their banding patterns on
sucrose density gradients (11).

By adding purified protein derivative

of Tuberculin (PPD) (the antigen In this case) to cultures of each of
these cell typeB, it was shown that only the culture supernatant
fluids from the T cell population (devoid of PPD) elllcited any
blastogenlc effect on non-sensltlzed target cells In a subsequent
assay.
By far the most common antigen system used to stimulate secretion
of HIMF in vitro Is the mixed lymphocyte culture (MLC) (7, 12, 13, 14).
This technique involves mixing allogeneic lymphocytes from two donors
which then stimulate cells In each population to produce a variety of
lymphokines (13).

Treating one of the cell populations with mitomycin

C prior to mixing, however, Inhibits Its DNA synthesis and permits only
the untreated population to respond to the treated cells' surface
antigens (12, 13, 14).

This technique is known as the one way MLC and

is helpful in reducing the number of lymphokine contaminants in the
supernatant.

In pioneering studies, Chess et al. (9, 15, 16, 17) separated
lymphocyte populations by immunoaffinity column chromatography and
discovered that only T cells proliferated In response to cell surface
antigens In an MLC and consequently produced HLMF (9).
Other evidence Indicating T cell production of HLMF lies in the
fact that patients with X-linked agammaglobulinemia show normal levels
of HLMF (8).

Since the disease is characterized by a deficiency in

plasmacytes, it may be assumed the B cell plays a minor role in HLMF
production.

In addition, athymic mice exhibit little or no LMF

activity while normal mice produce detectable quantities of the
lymphokine (18).
Findings by Mackler and Altman (18) showed lymphocytes that sponta
neously rosetted with sheep red cells were capable of Inducing, via a
soluble mediator, a mltogenlc effect on autologous cells.
Bacterial extracts (19), and products (14) have also been used
to induced HLMF synthesis.

Other antigens which have been used for

HLMF in vivo production studies Include PPD (15, 20, 21, 22), dinitrochlorobenzene (DHCB) (8 , 10, 23) and lymphocytes from donors sensitized
to tetanus toxoid (8 , 17, 23).
Earlier experiments designed to prove the existence of HLMF
explored the use of individuals sensitive to PPD.

Valentine and

Lawrence (20) observed that (a) when leukocytes from a donor sensitive
to both PPD and Diptheria-Pertussus-Typhoid (DPT) were Incubated with
PPD, the resultant supernatant material could transfer delayed hyper
sensitivity only for TB and not DPT, and (b) incubating cells with PPD
and then adding the activated supernatant fluid to naive lymphocytes
caused a 4-25 fold increase in radiolabelled thymidine uptake.

A prerequisite for HLMF production In an antigen system Is that
the producing cells must be obtained from positive individuals i.e.
persons previously sensitized to the particular antigen used (13).
A large portion of the Information on HLMF comes from studies of
mitogen-stimulated lymphocytes; pokeweed mitogen (PVM) (15), phytohemagglutlnin (PHA) (15, 18), and concanavalin A (con A) (15, 18, 24,
25, 26) have all been used with moderate success to generate HUtF.
The relative ease with which con A can be removed from culture
fluids by absorption to cross-linked dextran (Sephadex G-50) makes
the mitogen useful for stimulating lymphoklne synthesis.

The lectin,

con A, is a metallo-protein (29) containing manganese and calcium ions.
With a basic subunit of 23,000, con A forms dimers

predominant at

pH 5-6 and tetramers at alkaline pH In solutions of 1 M HaCl (30).
The binding site of con A to lymphocyte cell membranes Is specific for
a-D-manopyranose, o-D-glucopyranose or sterically similar residues
(31) and consequently is specifically inhibited by these sugars.
Reports concerning the partial purification of HLMF are difficult
to compare because of the divergent conditions utilized for the
production of this lymphoklne.

These differences raise the possibility

that the various investigators are not examining the same factor and
may account for some of the discrepancies in the biochemical para
meters of this factor.
Valantlne et al. (20) and Mainl (21) reported that HIHF
was heat stable at 56° C for 30 minutes , was not removed by
centrifugation at 100,000 x g and could stimulate both autologous
and allogeneic lymphocytes.

Kashura (7) noted that there was no

HLMF activity released from dead cells.
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Using actinomycin D, an Inhibitor of protein synthesis, It was
shown (14) that HLMF was not produced in treated cells stimulated with
mitogens.

This Indicated mltogenlc factor was evidently endogenous.

Treatment with trypsin or chymotrypsln resulted In loss of lymphoklne
activity while neuraminidase had no effect (8).
The molecular weight of HLMF is generally accepted to be around
25,000 (9, 25) as judged by Sephadex chromatography.

Other Inves

tigators (8), however, have noted that HLMF activity was excluded by
Sephadex C-200 indicating a molecular weight in excess of 100,000,
This may be due to polymeric forms of HLMF or complexes of HLMF with
a large carrier protein auch as a2-macroglobulln (32).
The Isoelectric point of HLMF is the only other molecular para
meter measured thus far (19).

Seravaili reported that the pi of

Group A Streptococcal filtrate-stimulated HLMF was 8 .0-8.5 sb evi
denced by the fraction's high mltogenlc activity on target cells.
Recently, Northroff et al. (33) reported that Incubating mono
nuclear cells i.e. T and B lymphocytes and monocytes, 2 to 5 days before
the addition of con A dramatically Increased the production of HIMF.
The active material was eluted from a Sephadex G-150 column in two
peaks at 12,000 to 27,000 and 50,000 to 70,000.

The effect of pre-

lncubatlon was abolished by the addition of fresh mononuclear cells
leading to the conclusion that suppressor T cells may regulate pro
duction of HLMF when stimulated with con A.
In addition to studies focusing on HLMF, mouse (28, 34, 38),
chicken (39), and guinea pig (38, 40-49) mltogenlc factors have been
similarly investigated.
In the guinea pig, ovalbumin-induced MF had an apparent molecular

7

weight of 20,000, a I>20W

x

cm^/sec, and Sj q ^ of

2.4 ± 0.25, and a partial specific volume of 0.71.

Zt wsb heat stable

at 60° C for 20 minutes or at 56° C for one hour (47).
Geczy (43) reported that MLC-lnduced and soluble-antigen-induced
MF were separate molecular entitles In the guinea pig.

The antigen-

stimulated MF, poBsesslng a molecular weight of 20,000-25,000 and an
Isoelectric point of 7.0-7.5, was unaffected by L-fucose whereas, the
MLC-lnduced MF, weighing 15,000-18,000 with a pi of 6 .0-6.5, was
Inhibited by L-fucose.
Antibodies prepared against MLC-MF Inhibited the MLC reaction.
This antibody did not affect the response of lymphocytes to FHA or PPD
and had no suppressive effect on PPD-MF.

Antibodies could not be

absorbed out with lymphocytes; thus, the antibodies probably were
directed against the MF rather than membrane antigens (43).

Soon after the observation that lymphocytes were capable of self
renewal came the realization that purified T cells could be maintained
in continuous exponential proliferative culture provided that condi
tioned medium from PHA-stlmulated lymphocytes was present (50, 51).
This discovery was confirmed and expanded by Glllis et al
(52) who concluded that a soluble T cell product was the active
moiety responsible for this effect and suggested the name T cell
growth factor (TCGF).

More recent studies showed that the mltogenlc

stimulus was delivered to the cell by TCGF rather than the lectin or
antigen.

Furthermore, it was found that the presence of a macrophage-

derived factor was required for the biological expression of TCGF
(53) .

This adherent cell product was termed lymphocyte activating
factor (LAF). LAF alone is not mltogenlc for T lymphocytes nor does
it support continuous T cell proliferation.

Instead, macrophages,

when activated by antigens or mitogens, secrete LAF which in turn
stimulates T cells to produce TCGF and augments the effect of the
mitogen (54).
The biological assay for LAF relies heavily on using high densi
ties of purified mouse thymocytes as target cells.

In the presence

of a suboptlmal concentration of a T cell mitogen, i.e. PHA or con A,
and LAF, the thymocyteB exhibit a marked proliferative response that
Is dependent on LAF concentration (54).
Since LAF Is a macrophage-derived product, mitogens specific for
these cell types, particularly 11 popolysaccharide (LPS), enhance its pro
duction (55) . Other Inducers include phagocytic stimuli such as phorbol
myrlstate acetate, antigen-antlbody complexes, and latex particles.

LAF

is also produced in mixed lymphocyte cultures which contain monocytes.
Although LAF may appear In an aggregated form, the apparent
molecular weight of the monomer was determined to be 13,000-15,000
by gel filtration (56-59).

That the molecule was protein was shown

by its sensitivity to chyraotrypsin.
LAF was apparently heterogeneous with respect to charge since
more than one charged species was resolved by DEAE-lon-exchange
chromatography and isoelectric focusing (58, 61).

Lachman et al.

(58) reported three isoelectric points at pH 5.2, 5.9, and 7.0,
with the major component of activity at pH 7.0.

The observed hetero

geneity probably was not the result of variation In sugar moieties
since LAF was unaffected by treatment with sodium periodate (60).

The most sensitive assay for TCGF Is simply a

3
H-thymidine up

take experiment using T blast cells which are transformed with PHA
(55).
PHA.

After transformation* these cells are no longer responsive to
They are, however, sensitive to TCGF, and are used to detect

Its presence.
Other workers employ a co-stlmulator assay In which the mitogen
is added (at suboptlmal concentrations) simultaneously with purported
TCGF-contalnlng supernatant fluids to PBL (62).

This results In

greater Incorporation of the radiolabeled thymidine than with the
mitogen alone.
TCGF was readily isolated from supernatant liquids of PHAstlmulated human lymphocytes by ammonium sulfate precipitation (63).
The concentrate was then applied to a DEAE-Sepharose column and
eluted with sodium chloride.

The active fractions were pooled,

concentrated by ultrafiltration and then subjected to molecular
sieve chromatography using Ultragel AcA54.

TCGF eluted from the

anlon-exchanger In 0.07 M NaCl and had an apparent
weight of 23,000.

molecular

The active moiety was sensitive to trypsin

digestion while deoxyubonudease (DNAase) and rlbonuclease (RNAase)
had negligible effects.
It is apparent then that lymphokines In all likelihood perform
an Immunoregulatory function during an Immune response.

Indirect

evidence for this phenomenon stems from Investigations of soluble
suppressor substances of Immune origin.
Using supernatant fluids derived from transformed lines, Vesole
et al. (64) noted that both mltogenlc and suppressor activities were
present In the same supernatant preparation but that separation of

Che two molecules by gel filtration was required to detect mltogenlc
activity In the bloassay.

This was apparently due to the masking

effect of the suppressor.

Similarly, It was suggested by Wolf et

al. (65), and later confirmed by Warren et al. (66) that tonsil
lymphocyte culture fluids contained both suppressive and T cell
growth factor activity.
The remainder of this discussion will consider various suppres
sor factors and their roles In the Immune response.

A rather broad

spectrum of molecules has been Implicated as suppressors of cellular
proliferation (DNA synthesis) of Immunocompetent cells.

These

Include prostaglandins, serum derived Immunosuppressive factors,
leukocyte extracts, complement-related factors, low density lipopro
teins, ct-l-acld glycoprotein, and lymphokines.
Prostaglandins, particularly the

and E2 series, were shown

to Inhibit the expected response of PHA-stimulated mononuclear cells
(67).

The suppression was noted In cultures containing glass-

adherent cells and was ablated upon treatment with indomethacin, an
Inhibitor of prostaglandin synthetase, or by dialysis of the super
natant fluids.
Rice (66) reported a prostaglandin suppressor system which
suppressed T lymphocyte proliferation.
corticosteroids
production.

The factor was resistant to

and did not depend on cellular division for Its

Baker et al. (69) showed that PGEp and PGE,j reduced

proliferation of differentiated cytotoxic

T

cells harvested from

T cell growth factor-dependent cultures by 43%.
Human leukocyte extracts obtained by freeze-thaw lysis were
growth inhibitory for a transformed B cell line and mitogen-treated
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peripheral blood lymphocytes.

The suppressor was dlelyzable through

3500 molecular weight cut-off tubing and may have been similar to
prostaglandins (70).
There have been several reports of serum components which Inhi
bited proliferation of activated lymphocytes.

Low density lipoprotein

(LDL) extracted from human serum was shown to Inhibit PHA- or poke
weed mitogen (PWM)-stimulated FBL and PBL In mixed lymphocyte cultures
(71).

The LDL had an apparent molecular weight of 2-3 x 10® and

contained 20-55% protein and 75-80% lipid.

The molecule migrated

electrophoretlcally In the 3 range and had a buoyant density of
1.055 g/ml In potassium bromide.

There was no loss of viability, .

and the suppressive effect waB evident Irrespective of mitogen
concentration.
Normal human plasma was shown to Inhibit lymphocyte stimulation
by PHA at suboptlmal (>1 Pg/ml) concentrations (72).

The suppressor

was non-dialyzable and stable when heated at 56° C for 30 mln.

It

was further shown that the plasma bound directly to PHA since delay
in adding the plasma to the PHA cultures reversed the effect.
Habict et al. (73) found that pooled human o-globulln fractions
(Cohn IV and V) suppressed the plaque-forming-cell (B lymphocyte)
response In mice.

The material was partially sensitive to trypsin

and contained llpld and/or carbohydrate moieties.
weight was determined to be 10,000-50,000.

The molecular

Isoelectric focusing

revealed four peaks of suppressive activity and three peaks of
enhancing activity.

This was confirmed by the dose response in which

both activities were revealed In a single preparation.
Nelken et al. (74, 75) isolated normal Immunosuppressive protein
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(HIP) from the a-globulin fraction of scrum of 24 hr whole blood.
This glycoprotein was

shown to Inhibit T cell and B cell DNA

synthesis, EL-4 tumor growth, and antibody-dependent cell-mediated
cytotoxicity.

The material was 10,000-25,000 In molecular weight

and was resistant to boiling.

The factor was not species specific,

had no effect on fibroblasts, and acted by a non-cytotoxic mechanism.
Benson et al. (76) also Identified a serum protein which sup
pressed a B cell response, the antibody response, to sheep red blood
cells.

The

suppressor was labile at 56° C for 30 mlnand was absor

bed by Immune complexes.

The factor

was shown to be

or

com

plement components but not C2 , C^, or Cg.
a-l-Acid glycoprotein (orosomucold), a serum protein produced by
the liver, was Bhown to be elevated during stress and pregnancy, concen
trated around sites of Inflammation, and found In Individuals with neoplasia.
Orosomucold

suppressed the response of mouse spleen

con A, LPS,

the antibody response to sheep red blood cells, and cell-

mediated cytotoxicity (77).

cells to PHA,

The carbohydrate content of the protein

was 45% of the weight of the Intact molecule and was necessary for
expression of biological activity.
The concentration of C-reactlve protein (CRP) was found to be
Increased In the acute stages of Inflammation, particularly In.pleural
effusions (78),

CRP inhibited ^H-thymidine Incorporation by lymphocytes

stimulated In mixed lymphocyte culture, diminished the response of PPD,
and caused a decrease in the production of migration Inhibitory factor
(MIF).

It was postulated that CRP may modulate the cell-mediated immune

response and may contribute to anergy I.e. unresponsiveness to antigen
insults associated with inflammation.
By far the most prevalent suppressors are proteins derived from

cells of the Immune response.

Larsson et al. (79* 80) demonstrated

the existence of a factor produced by PHA-stlmulated PBL which
Induced macrophages to become suppressive to PPD-stimulated PBL.
Green et al. (81) using PHA-stlmulated lymphocytes found a
factor which Inhibited the growth of a variety of transformed cell
lines.

Proliferation inhibitory factor (PIF) was non-dlalycable,

non-sedimentable at 90,000 x g for one hr, sensitive to trypsin, and
stable at 85° C for 30 tnln.

The suppressive effect behaved in a

dose-dependent manner, caused no loss of viability of target cells,
«

and was reversible when the target cells were removed from PIFcontalnlng media before 24 hrs.
A factor produced by T cell-enriched lymphocytes stimulated with
Insoluble con A was described by Williams et al. (82).

The factor

suppressed the mixed lymphocyte culture response without loss of
viability.

The activity was sensitive to chymotrypsin treatment,

non-dlalyzable, partially labile at 56° C for 30 mln, and sensi
tive to pH 2.0 after 24 hrs.

Treatment with neuraminidase resulted

in 15% loss of biological activity.

It was probable that this factor

was an a-lymphotoxln since antibodies directed against this family
of lymphotoxlns ablated the suppressive effect.
Other workers (83) have shown that treatment of PBL with con A
resulted in the elaboration of a substance suppressive for the mixed
lymphocyte culture and for cell-mediated lympholysis.

It was also

demonstrated that the suppressive effect was mediated by macrophages.
It was non-cytotoxlc, and did not require cellular division for the
expression of activity,
Shou et al. (84) used PHI. grown four days In culture without

u
serum or any stimulatory agent to produce a suppressor of con Astimulated PBL and mixed lymphocyte cultures.

The suppressive

material was stable at 56° C for 30 minutes, partially denatured at
70° C for 30 minutes and destroyed at 80° C for 30 minutes.

The

active moiety was non-cytotoxic.
Two soluble immune suppressor substances (SISS) were Identified
In PBL cultures stimulated with PllA or con A (85, 86).

SISS-T was

shown to Inhibit T cell mitogen and antigen responsiveness noncy totoxically.

The material wbb 30,000-45,000 d in size and was blocked

i.e. activity by H-acetyl-D-glucosamlne.

SISS-B Inhibited polyclonal B

cell activation (i.e. immunoglobulin production) noncytotoxically.
The suppressor was inhibited by L-rhamnose.
weight of SISS-B was 60,000-80,000

The apparent molecular

and was stable at pH 2.5.

Both

factors were heat labile at 56° C for 30 minutes.
Another soluble suppressor factor (SSF) produced by pokeweed
mitogen-stimulated PBL was found by Hoffman et al. (87).

The

factor was dependent on the presence of the macrophage for production.
SSF was shown to inhibit MLC, T cell cytotoxic activity, and the
generation of killer cells.

It was further noted that the suppressor

had to be present at the Initiation of culture for activity to be
expressed.
An inhibitor of DNA synthesis (IDS) was suggested by Jegasothy
et al. (68),

IDS was produced by con A-stlmulated PBL in 48 hrs and

inhibited PHA stimulation of PBL.

The factor was glycoprotein in

nature with the requirement of Intact carbohydrate moieties for
biological activity.

The suppressor appeared as a 20,000 d monomer,

but It was also found as a dimer, trimer, and tetramer in solution.
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IDS was sensitive to trypsin and periodate.

It was heat stable at

60° C for 30 min, had an apparent pi of 3.4, and was non-cytotoxlc
for target cells.
Another soluble Immune response suppressor factor (IRSF)
produced by non-adherent, unstimulated PBL was reported (Lederman
et al.),

IRSF suppressed PHA, PHM, and con A stimulation of PBL.

The activity was partially dlalyzable, stable at 56° C for one hr,
and Its production was unaffected by indomethacln.
Mixed lymphocyte cultures also were shown to produce a soluble
factor which suppressed cytotoxic lympholyslB and mixed lymphocyte
culture responses (90).

The production of the active moiety was

dependent upon the presence of antigen-sensitized lymphocytes and
required restlmulatlon of those primed lymphocytes in the primary
MLC.

Tibbetts et al. (91) used a nitrogen bomb to lyse PBL and found
that the cell extract comprised suppressive material which Inhibited
PHA stimulation of PBL noncytotoxically, mixed lymphocyte cultures,
and growth of the transformed B cell line PGLC-33H.

The suppressor

was DNAase resistant, trypsin sensitive, stable at pH 5.4-B.4, and
had an apparent molecular weight greater than 100,000 *
By separating tonsil lymphocytes on an albumin gradient, Wolf
et al. (65) demonstrated that a subpopulation of T lymphocytes
stimulated with PHA could suppress PBL mitogen responsiveness.
Furthermore, It was noted that the suppressive substance was produced
constltuitively In tonsil T cells.

The factor eluted predominantly

In the exclusion volume of Sephadex G-100 and was resistant to heating
at 60° C for 15 min.

Several Investigators used lymphoblastold cells as a source of
soluble Inhibitors of mitogen-stimulated PBL.

Green et al. (92) gen

erated crowded lymphoblast culture supernatant fluids and subjected
them to Ion exchange chromatography.

The suppressive fraction was

nan-dialyzable with an apparent molecular weight of 40,000-70,000.
The material was stable at 56° C for 30 min but thermolablle at 80°
C for 30 min.

It

was resistant to neuraminidase, and sensitive to

pronase and to pHbelow 2.4.

The suppression occurred without

cytotoxic effects on target cells.
Hersch et al. (93) Identified

a suppressor which possessed the

same characteristics as the factor described above.

It was shown to

be DNAase, RNAase, and trypsin resistant In addition to being pronase
sensitive.

Production of the Inhibitor was blocked by puromycln,

cyclohexamlde, actinomycin D, arablnosyl-6-mercaptopurine, and arablnosyl cytosine.

This Indicated cellular proliferation and protein

synthesis was required for Its expression.

It was postulated that

crowding of the lymphoblasts resulted In contact inhibition by pro
duction of an inhibitor via protein synthesis.
Other Investigators have found transformed cell culture super
natants to comprise suppressor molecules.

Using human B cell lines

(SWB-16, RPMI-1788, RPMI-6410) and one T cell line (CCRF-CEM),
Vesole et al.(94) Identified a soluble Inhibitor of PHA-stlnmlated
lymphocytes.

The active moiety co-eluted with albumin on Sephadex

G-100 and was reported to have two active lsoelectricfocuslng
fractions at pH 2.99-3,55 and 4.35-4.55.
An Inhibitor produced by transformed cell lines derived from
non-lymphoid tissue was noted by WerkmelBter (95).

The soluble
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material

whb

shown to Inhibit FHAt PWM, MLC responses as well as de

crease immunoglobulin production In a dose dependent manner.
As documented by the preceding literature review, there are a
myriad of mltogenlc proteins and suppressor proteins which are produced
by and/or affect lymphocytes. Until the advent of monoclonal antibodies
specific for lymphocyte cell surface antigens, it was Impossible to
determine precisely the cell population responsible for producing the
various lymphoklne activities.

This discovery coupled with fluorescent

activated cell sorting has lead to the identification of at least two
•f
_
distinct T lymphocyte subpopulatlons, TH4 and TH^ .

It has been

shown that the T helper subpopulation (TH^+) produces TCGF.

Although

there Is no direct evidence available, It is presumed that the suppressor
cell subpopulation (TH^~) produces soluble suppressor factor(s).
Furthermore, It Is known that tonsil lymphocytes contain the suppressor
subpopulation in question and, therefore, it is probable that these
cells produce a soluble factor capable of inhibiting the proliferative
response of PBL to mitogens or antigens.
This report presents evidence which suggests that tonsil cell
culture supernatant fluids comprise substances which are suppressive and
stimulatory for allogeneic PBL.

OBJECTIVES
A major obstacle la lymphokine research Is obtaining enough
homogeneous material for biochemical analysis.

Initially, It was

thought that tonsil lymphocytes would provide a large and readily
available source for human lymphocytes and that, when stimulated
with mitogens, these cells would produce substantial quantities of
HLMF.

It was found, however, that tonsil cells were not only

undergoing blastogenesls without in Ditto stimulation, but that
these cells, grown without serum or in vitro stimulatory agents,
constltultlvely produced three discreet soluble factors which
affected the proliferation of allogeneic PBL in different ways.
Since there were different activities present In the same
supernatant fluids, was It possible that the factors were involved
In regulating cellular proliferation of immunocompetent cells?
In order to address this problem, It was necessary to obtain purified
material of each active moiety for the purpose of biochemical
characterization.

This report describes our observations and

presents biochemical data defining some molecular parameters of
a suppressor factor, and two mitogenic factors.

CHAPTER 2
MATERIALS AND METHODS
Preparation of Tonsil Cell Culture Supernatants.

Palatine tonsils

were removed from 3-16 yr old patients undergoing elective surgery for
recurrent tonsillitis.
post-lnfectlon.

The surgery was performed at least two weeks

The organs were placed Immediately In Ice cold RPMI-

1640 medium (Flow Laboratories) supplemented to triple strength (3X)
with penicillin (300 U/ral), streptomycin (300 pg/ml) (Grand Island
Biological Co.), gentamycln 100 Mg/ml) (Sigma Corp.), fungisome
(2 yg/ml) (Grand Island Biological Co.), and HEPES (25 mM) (Fig. 1) for
transport from the hospital to the laboratory.

Within two hr, the

tissue was sliced In the laboratory Into small sections and gently
pressed through a fixed 80-mesh screen (Cellector:
Co).

E. C. Apparatus

The cells were collected In a petrl dish containing 30 ml of

supplemented RPMI-1640.

After centrifugation at 50 x g for 10 min to

remove the large debris, the mononuclear cells were separated by flo
tation on Ficoll-Paque (Pharmacia Fine Chemicals) and counted on a
hemacytometer.

Tonsil cell preparations with less than 85X viability,

as determined by trypan blue exclusion (96), were not used.

The cells

were adjusted to yield a final concentration of 4-5 x 10** viable
cells/ml In RPMI-1640 supplemented with penicillin (100 U/ml), strepto
mycin (100 pg/ml), and gentamycln (40 pg/ml) (IX).

These primary

cultures were Incubated in Coming 150 cm^ tissue culture flasks
(Corning Glass Works) for 24 hr in 95Z air-SZ COj at 37° C.
Culture samples were examined for the presence of bacteria by the
gram stain, and by growth on blood agar plates or In thloglycollate
solution.
of yeasts.

Sabouraud's agar plates were used to test for the presence
Contaminated cultures, which were rare, were discarded,
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Figure 1.

Scheme for preparation of tonsil cell

supernatant cultures.

Tonsil placed In
ice cold (3X) RPMI-1640

\

saBed apart;
Tissue teahed
Pressed through 80 mesh screen
Into 30 ml (3X) RPMI-1640

i

Centrifuge 50 x g
to remove debris

t

Supernatant layered
ired on Ficoll-Paque;
00 x g for 40 min
centrifuged 400

1

Mononuclear fraction
removed by .aspiration

t

'ashed X 2
Cells washed
in 3 X RPMI-1640

Final pellet suspended
to 4 x 10^ viable cells/ml
in serum-free C1X) RPMI-1640

f

Incubate 24 hrs at
37° C in 95X air-5X C02

Cultures terminated
by centrifugation

Supernatant Lyophilized
Rehydrated in.small volume

1•- 1“

7

Supernatant: dlalyzed
against 0.05 M MH^HCO^ pH 7.3

Lyophilized

I

Stored -80° C
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The cultures were terminated by centrifugation at 400 x g for 10 min.
The supernatant fluids were then concentrated by lyophlllzatlon end
centrifuged at 100,000 x g for 1 hr at 10° C In a 35 TI (Sorvall)
rotor to remove Insoluble matter.

These supernatants were frozen,

or dialyzed against 0.05 M NH^HCO^ solution, pH 7.3, and lyophilized
in both instances, the samples were stored at -85° C.

Prior to

testing for activity In the bioassay, lyophilized Bupematants were
rehydrated In5.0 ml of phosphate-buffered saline (PBS: 0.15 K NaCl,
0.0076 M Ha 2HP0^, 0.0024 M N a ^ P O ^ ; p H 7.2) and dialyzed againBt the
same buffer to remove residual ammonia.

They were finally dialyzed

in supplemented (IX) RPMI-1640.
Bloassays.

Blood was obtained In heparlnized (10 U/ml) syringes

by phlebotomy of normal adult humans.

The lymphocytes were prepared

by flotation on Flcoll-Paque (Fig. 2).

The mononuclear cell layer

was removed by aspiration, and the cells were washed three times
with Hank's balanced salt solution.

Recovery of washed cells was

accomplished by centrifugation at 400 x g for 10 min.

The washed

cells were suspended In a small volume of RPMI-1640, and viability
was determined by trypan blue exclusion.
The PBL were adjusted to 2 x 10*> viable cells/ml in supplemented
RPMI-1640 made 20% with human AB+ serum (Flow Laboratories). Assays
were done In sextuplet (unless otherwise noted) In flat-bottomed
96-well Falcon Micro Test II sterile tissue culture plates (BectonDlckenson and Co).

Each well received 0.1 of the cell suspension,

and 0.1 ml of tonsil cell culture supernatant which had been dialyzed
against supplemented RPMI-1640 and fdlter-sterlllzed with a 0,22 ym
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Figure 2.

Suppressor/augmentor and mltogenlc

factor bloassay protocols.

PBL Isolated
on Ficoll-paque
and waBhed X 2

I

USpi
Cell suspended
to 4 x 10® viable cells/ml
In RPMI-1640 with
20% AB+ serum

0.1 ml of cell suspension
0 .1 ml of tonsil supernatant
added to micro culture wells
Suppressor/Augmentor
Control: 0.1 ml RPMI-1640
0.1 ml cell suspension

/

Mitogenlc Factor
Control: 0.1 ml RPMI-1640,
0.1 ml cell suspension

10 pg/ral Con A added
(25 pi) to each well

\

Incubated 72 hrs
at 37° C in 95%-5%

\
I

1 liCi
uCi 3H-thymidine;
H-th
Incubated 12-15 hrs

Assay harvested
on MASH II with
glass fiber filters

I

Filters placed
in
pi
plastic minivlals
with 4.0 ml Sclntlsol
and counted
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filter (Gelman Sciences) before being used in the bloassey.
Suppression and augmentation were determined by the ability of
the tonsil cell supernatants to reduce or augment the Incorporation
of

H-thymidine by the PBL upon addition of con A to the wells.

A (Mlles-Yeda) was suspended in a solution of 1 M NaCl and 10

Con
M

MgC^, CaClji and MnCl2 < The concentration of the con A In the
stock solution was 750-800 pg/ml as measured by Its optical density
(E^qq

13).

The stock was diluted to 80 pg/ml with supplemented

RFMI and 25 pi were added to each well for a final concentration of
10 pg/ml.

The plates were Incubated three days at 37° C In 952 air-

52 C02 before the addition of 1 pCl (6 Ci/mMole).

The cultures were

Incubated another 12 hr, and then harvested with a HASH II (Micro
biological Associates).

The glass fiber filters (Whatman 934 AH

or GF-C) were dried, placed in plastic mlnl-vlals containing 4,0 ml
of Sdntlsol (Isolab), and radioactivity waB determined in a Beckman
3155T Scintillation Counter pre-set at 1.02 error.

Background counts

per minute with vials containing Sclntlsol were 25 ± 5. The controls
were cells cultured with medium made 202 in AB+ serum, with and without
con A, in the absence of supernatant fluid.

Counts per minute and

standard deviations (n ■ 6) were recorded.
After determining radioactivity, suppression wsb calculated
using the formula:
2 Suppression - (1 -

cPm suppression supernatant ) X 100
cpm con A-stimulated control

Target cell viability was examined by the trypan blue exclusion
method (96).

In some cases, trypan blue was added directly to the
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tnlcroculture wellB Just prior to termination of the bloossay.
Augmentation was calculated using the formula:

X Augmentation *

( cPm augmentation supernatant
cpm con A-Btimulated control

x ^qq

In experiments measuring mitogenlc activity, the same assay was
employed but con A was absent from the wells.

The mitogenlc Index

(M.I.) was then calculated by the formula:
M. I. *

cpm of tonsil supernatant
cpm of AB+ serum control

Primary Culture Blastogenesis.

PBL and tonsil lymphocytes were

tested for their ability to Incorporate ^H-thymidine in the absence of

in vitro stimulation.

Lymphocytes Isolated by flotation on Flcoll-

Paque were suspended In supplemented (IX) RPMI-1640.
of 4 x 10® cells/ml were used.

Concentrations

Aliquots of 0.2 ml of the cell

suspension were added to flat bottom microculture plates.
were Incubated for 24 or 48 hr at 37° C In 95% air-5% CO2 .
prior to harvesting the assay 1 yCi of
added.

The cells
Twelve hr

H-thymidine (6 Cl/mmole) was

The assays were done In sextuplet.

The cells were harvested

and the Incorporation of radioactivity was done as described earlier.
Protein was determined by the modified Lowry method (97).■
Dose Response. Lyophilized tonsil lymphocyte supernatant fluids
were rehydrated with PBS to give a 16-fold concentration of the
original supernatant volume.

Serial dilutions were made In supple

mented RPMI-1640 which then were assayed for suppression as described.
Supernatants which had augmenting and mitogenlc activity were
rehydrated in PBS to a concentration of 60-fold.

Serial dilutions
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were made in supplemented RPMI-1640 and then assayed.

Protein was

determined using a modified Lowry method (97)•
Statistical Analysis.

To determine the statistical significance

of suppression or augmentation, the difference between means of
test supernatant and control supernatant ± 95% confidence limits about
the difference was calculated.

The confidence limits were constructed

using Dunnett's Q* ( 98) statistic and the standard error of the
difference used to establish the limits was computed from the error
mean square of a one-way analysis of variance (ANOVA).
The fit of dose response data for mitogenicity and augmentation
to a straight line was estimated by least square linear regression.
When individual comparisons were made between experimental
and control values, Dunnett's test was used (PL.05).
Trypsin Sensitivity.

Immobilized trypsin (1238 U/gi Millipore

Corporation) was washed repeatedly in several volumes of 0.1 M TrisHC1 solution, pH 8.0.

Concentrated supernatants with biological

activity were dialyzed against the same buffer.

A small aliquot of

each dialyzed supernatant was reserved to serve as control, and the
remainder was treated with 50 pg of the washed enzyme for 1 hr at
room temperature.

The reaction was terminated by the addition of 10

pi of dilsopropylphosphofluorldate (DFP) (.054 M).

Each sample then

was centrifuged at 100 x g to remove the immobilized trypsin and
the supernatants were dialyzed against PBS to remove unreacted
DFP.
Gel Filtration Chromatography.

Concentrated crude suppressor-

active supernatant fluids were fractionated using columns (1.5 x
90 cm) of Sophadex C-100 (Pharmacia Fine Chemicals), The gel
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matrix waa equilibrated with NH^HCOj (0.05 M, pH 7.3).

Aliquots of

100 pg of 60 X concentrated supernatant material were weighed out and
rehydrated In 2 ml of PBS, dialyzed against the ammonium bicarbonate
buffer and applied to the column.

Fractions of 2 ml were collected

and their protein content determined by OD2go>

The fractions were

pooled as shown In Fig. 5, lyophilized, rehydrated in PBS and dialyzed
against supplemented RPMI-1640 In preparation for blbassay.

The

column was calibrated with the following molecular weight standards:
bovine serum albumin (mol wt 68 ,000), carbonic anhydrase (mol wt
29,500) and myoglobin (mol wt 17,200).

Blue dextran (0.12) waa used to

determine the exclusion volume.
Isoelectric Focusing.

Preparative isoelectric focusing was done

using Ampholytes 3-10 (LKB) or Pharmalytes 3-10, 4-7, and 5-8
(Pharmacia Fine Chemicals) with Ultradex (LKB) serving as the support
medium.
Supernatant fluids exhibiting suppressive activity In the
bloassay were concentrated by lyophlllzatlon, rehydrated In PBS to
a final concentration of 60 X and then dialyzed against 12 glycine
solution pH 7.2.
gel slurry.

After dialysis the experimental sample was mixed with the

Plates 3 mm in depth were prepared and allowed to dry

to the evaporation limit at room temperature.

The gels were then

focused at 10° C using an LKB multiphor apparatus.

Electrophoresis

was at 8 watts constant power until no further drop in mllliamperage
could be detected.

A control gel incorporating an identical mixture

of Pharmalytes and Ultradex but containing no protein was treated
under the same conditions.
The pH gradient was determined using an LKB Multlphore electrode.
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The gel bed then was cut Into 12 equal sized sections.

Each was placed

In a plastic funnel and eluted with 3-5 ml of deionized water.

To re

move residual Pharmalytes, the eluates were dialyzed against PBS.

Poly

ethylene glycol 6000 (Eaatman Kodak Co) was Included in the dialysis
buffer to help stabilize protein.

The protein content of each fraction

was determined by 0D2qq on a Carey 219 Spectrophotometer (Varlan) or by
a modified Lowry technique (97).

Nucleic acid was measured by ODjgo.

The eluates finally were dialyzed against supplemented RPMI-1640 and
subjected to the bloassay.
Ion-Exchange Chromatography.

Anion exchange resin DE-52 (Whatman)

was equilibrated in tris-HCl buffer (40 mM, pH 7.2; start buffer) and
columns 0.9 x 15 cm (packed gel) were prepared with the pressure head
aet at 30 cm.

Aliquots of 1.0 ml (200 pg) of concentrated supernatants

having suppressive or augmenting activity were dialyzed against the
starting buffer and then layered on the gel.

The column was washed with

two volumes (20 ml) of starting buffer before beginning the linear
gradient of 1 M NaCl.

The elution rate was 20 ml/cm^/hr.

Conductivity of the 2-ml fractions was determined using a conduc
tivity meter (Radiometer CDM 2) and each fraction was examined for total
protein OD220 or nucleic acid by OD260*

A small aliquot of the crude

preparation was used for comparison purposes.

Fractions were pooled as

indicated in RESULTS, dialyzed against PBS, and lyophilized.

The dried

material was rehydrated with deionized H 2O In a small volume and dia
lyzed first against PBS, to remove salt and then against supplemented
RPMI-1640 in preparation for bloassay.
To determine specific activity of the suppressive material,
several supernatants were separated by anion exchange chromatography.
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Preliminary data Indicated the 0.4 M to 0.6 M fraction to contain
suppressive material; therefore, this fraction was used in the
bloassay.

An aliquot of the crude preparation was tested simulta

neously with the partially purified material.
Protein was measured by 0D2qq.

Specific activity (S. A.) was

then calculated by:

S. A.

-

% Suppression
O.D.20O units

Immunoelectrophoresis.

Commercially prepared agarose Immuno

electrophoresis plates equilibrated with sodium barbitol (pH 8 .6 ,
ionic strength 0.05) were used to examine culture supernatant for
the presence of human immunoglobulins and a2-macroglobulin. Tonsil
cell supernatants that demonstrated a suppressive effect in the
bloassay were lyophilized and rehydrated in PBS to give a 120-fold
concentration with respect to the original supernatant volume.

A

small aliquot wsb dialyzed against the barbitol buffer Just prior to
use.

Volumes of 50, 100, 150, or 200 pg were added to the wells and

electrophoresis was carried out using a Corning 700 electrophoresis
Power Unit for 30 min.

Pooled human AB+ serum served as a

control.
Pooled goat antisera to human IgG, IgA, IgE, IgM, and commercially
prepared (Cappel Laboratories) a2-macroglobulln antisera were added to
appropriate troughs and allowed to diffuse overnight.
antibody was removed by soaking the plate in PBS.

Residual

The plates were

stained with thlazine red (12), destalned in acetic acid (52), and
photographed.
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Temperature Sensitivity.

Suppressor-active supernatants were

tested for thermal stability at 56° C for 30 min, 80° C for 10 min,
and 100° C for 5 min.

Aliquots of 0.5 ml of concentrated (60 X)

material rehydrated in PBS were placed In 1-ml pyrex test tubes
with stoppers.

Bach sample was placed In water bath set at the

appropriate temperature.

After the sample had reached the appropriate

temperature, timing was begun.

The samples were removed, dialyzed

against supplemented RPMI-1640 and assayed for suppressor activity.
Polyacrylamide Gel Electrophoresis.

Standard alkaline gel

electrophoresis was done as described by Brewer et al. (99).
Acrylamide (Bio-Rad Laboratories) gels 6.5 mm containing 7.5% TEMEDpolymerized acrylamide were cast in 0.7 x 8 mm glass tubes.

A

solution of 3.75% acrylamide was layered on top and photopolymerized
with riboflavin (Bio-Rad Laboratories) to form stacking gels.
Aliquots of 50-100 pi of the 60 X concentrated crude suppressor
preparation or the 0.5 M-0.6 M anion exchange fractions were
dialyzed against the electrophoresis buffer (trls, 5 mM; glycine,
38 mM; pH 8,9) and applied to the gels with an Adams suction apparatus
(VWR Scientific, Inc).
concentration of 10%.

Sucrose was included In each sample to final
Human serum albumin (100 pi of 500 pg/ml),

|

pooled AB

serum (10 pi of 100%) and ovalbumin (100 pi of 500 pg/ml)

were used aB controls.
The gels were electrophoresed In trls-glyclne buffer at 1.0 mA
per tube until the dye exited the stacking gel.

Then the current was

Increased to 1.5 mA for the remainder of the electrophoresis.
Gels were stained for protein by one of the following methods:
(1) Formaldehyde-Coomassle Blue (100). Proteins were fixed and stained
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for 3 hrs in 700 ml of an aqueous solution of ethanol (242 u/v)
formaldehyde (52 v / v )

and

containing 0,8 gm of Coomassle Brilliant blue

R-250 (Eastman Kodak Co).

Destalnlng was affected with an aqueous

solution of ethanol (772 v / v ) and formaldehyde (12 u/u) overnight
In a gel electrophoresis diffusion destalner (Bio-Rad Laboratories).
(2) Periodic acld-Schlff reagent (PAS).

Glycoproteins were sought

by a PAS technique (101). The protein was fixed In 12.52 trichloroacetic
a d d solution for 1 hr, and oxidized with 12 periodic acid solution
for 2 hr.

The gels were washed In 152 acetic acid for 2 hr and then

reacted with Schlffs Reagent (Fisher Scientific) for 2 hr at 4° C
In the dark.

Destalnlng was with 152 acetic a d d .

Ovalbumin served

as a control for the PAS method.
Stained gels were photographed with a Minolta X D 35 mm camera
(Minolta Corp) containing Plus X Pan 125 black and white film
(Eastman Kodak, Co).

A light orange filter (Tiffen Inc) was placed

over the lens to help reproduce the lighter staining bands.
Chromatofocuslng.

Suppressor active supernatants were fraction

ated by chromatofocuslng. The concentrated crude preparation was
dialyzed against a start buffer of 0.025 MM lmldazole-HCl, pH 7.4
overnight at 4° C.
Chromatographic columns (9 mm x 15 cm) were fully packed with
PBE-94 (Pharmacia Fine Chemicals) and the gel beds equilibrated with
several column volumes of start buffer until the eluted buffer
registered pH 7.4.
Polybuffer 74 (Pharmacia Fine Chemicals), was titrated to pH 4.0
with 0.5 N HC1, diluted (1:8) to the appropriate volume, and the pH
readjusted to 4.0.

Five ml of the eluent buffer was run onto the
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column and then 0.5 ml of the dialyzed supernatant was applied.
The elution was continued with the polybuffer using a pressure head
of 30 cm.
Fractions of 2.0 ml were collected until no further drop in the
pH could be detected.
pools of equal volume.

The fractions then were combined Into six
The pools were placed In dialysis tubing

with a 14*000 molecular weight exclusion limit

(Spectraphor)

and dialyzed against two* four liter volumes of 0.05 M NH4HCO3 ,
pH 7.2 overnight at 4° C.

The material was lyophilized* rehydrated

with PBS to 0.5 ml* dialyzed against PBS and then supplemented (IX)
RPMI-1640 before bloassay.
In one experiment* the pools were concentrated by Amicon filtra
tion In a step wise fashion.

The pools were first concentrated on a

YM 50 membrane (Amicon Corp) followed by reconcentration of the eluate
on a YM 10 membrane.

The retentates of each filtration were washed

repeatedly with PBS until the pH of the filtrate was equivalent to
the buffer.

Both the 50*000 and 10*000 retentate fractions of

each pool were assayed following dialysis against (IX) RPMI-1640.
To determine the effects of non-dialyzable polybuffer consti
tuents on the bloassay* a small aliquot of Folybuffer 74 was titrated
to pH 4.0 and diluted (1:8) to the appropriate volume.

The buffer

solution was dialyzed as described above and assayed.
Separation of Adherent and Non-adherent Cells.

To determine the

cell population responsible for producing the augmentor* tonsil cells
were separated into plastlc-non-adherent and plastic-adherent popula
tions in the following manner.

Tonsil cultures were Incubated for

2 hr In plastic tissue flasks containing supplemented RPMI-1640 (IX)

under normal conditions.

The non-adherent cell population was then

decanted Into another flask and incubated for an additional 22 hr.
The adherent cells were reconstituted in fresh RPMI-1640 and Incubated
for 22 hr.

The control cultures were treated in the usual manner.

CHAPTER 3
RESULTS
The Proliferative Activity of the Tonsil Cells.

As shown in Table

1, the amount of radioactivity Incorporated hy PBL in culture for 24
hr or 48 hr was low, and typical of what was routinely accepted as
"background" level for unstimulated PBL.

Conversely, some tonsil

lymphocytes showed greater than a tenfold higher incorporation of
thymidine compared to that taken up hy PBL at 24 hr (Table 1).

H-

In

addition, a significant decrease in actual cpm was observed at' 48 hr.
The proliferative activity in a 24 hr period of tonsil lymphocytes
from among the many tonsils studied varied widely, hut was usually
greater than that of PBL.

The number of proliferating cells in the

population was not determined.
Effect of Tonsil Cell Culture Fluids on the Con A-Induced Pro
liferation of Normal PBL.

As demonstrated above the tonsil cell popu

lation was in an activated state when compared to PBL.

It was

also found that supernatant culture fluids generated in the absence
of in vitro stimulation of the tonsil cells often Inhibited the
proliferative response of PBL to con A.
Tonsil cells were cultured in the absence of serum for 24 hr.
After recovery of the supernatant fluids, they were centrifuged at

100,000 x g, to remove Insoluble particulate matter, and then tested for
their effect on the incornoratlon of
with con A.

H-thymidine by PBL cultured

The data are presented in Table 2.

Of 29 different

tonsil cell supernatants assayed, 24 significantly suppressed the
Incorporation of ^H-thymldine by PBL cultured with con A.

The extent

of suppression ranged from approximately 22% to 84% with the average
being 43%,

Five of the tonsil fluids had little or no effect on the
33
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TABLE X
Unstimulated Proliferative Activity in vitro
of PBL and Tonsil Cells

Sample
Number

Incorporation of ^H-thymldlne*2
24 hr

48 hr

PBLb
1

4,574 ± 714

1,350 + 524

2

1,177 + 130

1,235 ± 88

3

1,279 ± 284

1,350 ± 1,314

4

1,156 ± 371

1,463 ± 240

5

1,264 ± 427
Tonsil Cells^

1

13,940 ± 1,184

7,340 ± 604

2

7,631 1 494

4,330 ± 286

3

12,093 ± 1,227

10,545 ± 780

4

14,705 ± 1,196

5

11,399 ± 1,639

6

12,253 1 1,272

7

18,085 ± 2,481

8

9,265 ± 2,230

9

11,187 ± 1,640

10

9,964 ± 1,010

11

5,262 ± 535

12

21,596 ± 1,991

13

9,064 ± 642

14

9,383 ± 483
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TABLE 1
Unstimulated Proliferative Activity in vitro
of PBL and Tonsil Cells (Cont)

Sample

Incorporation of ^H-thymidinea

Number

24 hr

48 hr

Tonsil Celled
15

4,516 + 411

16

2,445 ± 390

17

5,120 + 759

18

3,029 + 668

19

9,288 ± 1,415

20

10,597 ± 1,100

21

1,937 ± 368

22

2,717 + 297

23

5,714 ± 960

24

3,656 ± 450

a Cells were cultured in microculture trays without stimulation for
24 hr or 48 hr.

Twelve hr prior to harvest, 1 pCi ^H-thymidine was

added to the wells.
^Mean cpm ± S.D. n - 6 .
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TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation
of Normal PBL Stimulated with Con Aa

Experiment

Sample

Number

Number^

1

Con A°

2

A Meon^*

Signif.M

107,021 + 12,022

2

99,405 ± 7,327

3

31

-32,988

4

18,806

+

7

- 7,616 ± 18,806

-

95,483 ± 14,103

11

-11,538 ± 18,806

-

4

95,803 + 8,818

12

-11,218 ± 18,806

-

5

95,128 + 9,405

11

-11,893 ± 18,806

-

23

-17,884 ± 20,098

-

Con A

Con A

79,793 + 14,494
61,909 + 6,940
54,660 + 7,515

7

35,578 + 4,875

45

-19,082 ± 8,108

+

8

41,441 + 2,901

24

-13,219

7,606

+

9

11,394 + 858

79

-43,266 ± 8,108

+

84

-46,165 ± 8,108

+

39

-39,302

4

14,712

+

4

Con A

11
5

Suppression6

74,023 + 22,846

10
4

CPJ^

1

6
3

X

Con A

8,495 ± 1,397

4

100,067 + 6,745
60,765 + 8,570
88,953 ± 1,631

12

34,251

4

3,464

61

-54,702

6,589

+

13

52,713

4

4,370

40

-36,240 ± 6,589

+
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TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation
of Normal PBL Stimulated with Con Aa (Cont)

Experiment
Number

Sample
Number^

CPf^

Suppression6

A Mean/'

Sipnlf.^

Con A°

72,382 ± 3,982

14

39,783 ± 2,971

45

-32,599 ± 6,735

+

15

41,412 + 4,531

42

-30,970 ± 6,735

+

16

43,049 ± 6,523

. 40

-29,333 + 6,735

+

17

47,665 + 4,406

34

-24,717 ± 6,735

4"

Con A

47,249 + 21,180

18

22,802 + 2,855

52

-24,447 ± 5,169

4*

18

29,108 ± 3,517

38

-18,141 ± 5,421

+

Con A

132,621 ± 16,834

20

48,084 ± 11,442

64

-84,537 ± 24,745

+

21

39,236 ± 6,200

70

-93,385 ± 24,745

+

22

83,574 ± 15,289

37

-49,047 ± 24,745

+

23

89,868 ± 14,854

32

-42,753 ± 24,745

4*

24

104,069 t 18,105

22

-28,552 ± 24,745

4-

25

71,734 ± 5,267

46

-60,887 + 24,745

4-

26

103,933 + 9,847

22

-28,688 + 24i745

4-

30

-40,090 i 24,745

4*

27
Con A

92,531 ± 17,785
64,118 ± 13,646

28

48,828 ± 5,694

24

-25,289 ± 11,936

+

29

46,195 + 6,381

28

-17,923 ± 11,936

+

TABLE 2
Effect of Tonsil Cell Culture Fluids on Transformation
of Normal PRI. Stimulated with Con Aa (Cont)

aTonsil cells were cultured in the absence of stimulation.

The

supernatants were assayed by their effect on PBL cultured in the
presence of con A,
^Numerals refer to individual patients' tonsils.
ffCon A refers to radioactivity incorporated by PBL stimulated with
con A in the absence of tonsil cell culture fluid.
^Mean cpra ± S. D. n « 6 .
ePercent suppression of radioactivity incorporated by PBL stimulated
with con A in the presence of tonsil cell culture fluid compared to
that incorporated in the absence of tonsil cell culture fluids as
described in text.
^The difference between means of test supernatant and control ± 95JE
confidence limits about the difference.
^The error used to calculate limits was from analysis of variance.
(+) indicates significant suppression.
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PBL target cells.

In all experiments target cell viability was 90%

or greater, regardless of the suppressive effect of the tonsil cell
supernatant.
Suppressor supernatant fluids were examined for protein according
to Lowry (97) and for primary culture blastogenesls (Table 3).

From

this, one might predict that an Increase in total protein would be
accompanied by an increase in the primary culture cpra.

However, when

the measured parameters of supernatant fluids 9 and 10 were compared
it was evident that, although they comprised approximately equal
amounts of protein (Table 3), there was considerable difference in
the degree of non-induced blastogenesls.

Similarly, one would expect

a concomitant Increase in total protein and suppressor activity or
in the amount of blastogenesls in the primary culture and suppressor
activity.

This, however, was also disputed by the data.

It was

concluded, that there was no apparent relationship between total
protein In the crude supernatant preparation and blastogenesls nor
between protein and blastogenesls and suppressor activity.
Absence of Immunoglobulins and a2-Macroglobulin In Suppressor
Supernatants. The tonsil cell supernatants were tested by Immuno
electrophoresis for immunoglobulins (Fig, 3).

There was no evidence

for the presence of immunoglobulins G, A, M, E or a2-macroglobulin in
suppressive supernatants.

The visible patterns of the control lndlca-

A
ted the antiserum used was reactive towards the AB serum antigens.
Dose Response of Suppressor-Actlve Supernatant.

The suppressive ef

fect of various concentrations (8 ■ 1 mg) of supernatant fluid is illus
trated In Fig. 4.

The amount of suppression Increased as the concentration

of the supernatant waB raised.

In several experiments of this kind.

40

TABLE 3
Comparison of Percent Suppression with Total Protein
and Nan-Induced Blastogenesls of Primary Culture

Primary Culture Parameters

Bioassay of
Primary Culture

Protein
Supernatant Concentration Volume
(ml)fc

Blastogenesls

Percent Suppression

(cpm)°

(cpm)^

Number

(ug/ml)a

1

50

50

4,516 ± 411

11

2

90

250

1,937 ± 368

23

3

100

550

9,383 ± 483

12

4

115

150

9,064 ± 642

11

5

130

300

21,596 ± 1,997

7

6

150

167

29,285 ± 1,951

45

7

265

550

14,985 ± 1,755

36

8

300

550

7,967 ± 843

83

9

330

300

5,262 ± 535

31

10

330

600

7,373 ± 1,188

40

11

340

600

7,193 ± 871

44

12

380

200

9,993 ± 499

30

13

400

200

9,522 ± 466

18

14

420

350

11,629 ± 227

87

15

580

1,000

12,430 i 1,433

64

TABLE 3
Comparison of Percent Suppression witti Total Protein
and Non-Induced Blastogenesls of Primary Culture (Cont)

a Protein concentration (pg/ml) in primary culture supernatant
preparation as determined by Loury technique (97).
^Volume of original supernatant fluid (ml).
^cpm ± S. D. (n * 6) of non-induced blastogenesls of primary
culture.
^Percent suppression*In bioasBay of primary supernatant culture
fluids.

Figure 3.

Immunoelectrophoresis of suppressor

active supernatant preparations,

Allgots of 5, 10,

15, or 20 ul of pooled human AB+ serum (A, C, E, G)
or 100, 150, 200 ug of concentrated crude suppressor
supernatant fluids (B, D, F) were added to the wells.
Fooled goat antisera to human IgG, A, M, F., and o2macroglobulln were added to each troughs.
was developed as described in text.

The plate

A

G

43

Figure 4.

Suppression of con-A activated PBL by

different concentrations of tonsil cell supernatant.
Concentrated crude preparations were serially diluted in
RPM1 1640 (8 ■ 1 mg crude protein) and submitted to the
suppressor/augmentor assay.

I00 -

S

80-

c

£

60-

a.

a
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4020t------ r

I

2

^Supernatant

j

44
It became apparent that a two-fold concentration usually produced
significant suppression.
Thermal Stability of Suppressor-Active' Supernatants. Suppressoractive supernatants were tested for thermal stability at 56° C, 80° C,
and 100° C.

The results are shown In Table 4.

The suppressor activity

was partially denatured at 80° C for 10 mln while 100° C completely
eradicated the activity.

No loss of activity was noted at 56° C for

30 mln (data not shown).
Effect of Trypsin.

Immobilized trypsin completely destroyed the

suppressive activity in four of the six active supernatants (Table 5),
and about 67JK of the activity In another supernatant (No. 2) was
destroyed.
however.

Only 26% of the activity of sample six was destroyed,
These data suggested that suppressor activity was attri

butable to protein.
Molecular Sieve Chromatography of Suppressive Material. Molecular
sieve chromatography was used to Investigate the apparent molecular
weight of the suppressor substance.

The elution profile of concen

trated suppressor culture fluid on Sephadex fi-100 Is shown in Fig. 5.
The majority of suppressor activity eluted In the exclusion volume
and corresponded to an apparent molecular weight >100,000 d (Fool 1).
A small amount of detectable activity was also noted In the 68,000 d
range (Pool 2).

Pool 5, as shown by hatching, contained augmenting

activity and will be discussed below.
Ion Exchange Chromatography of Suppressor-Active Supernatant.
Concentrated suppressor-active supernatant fluids were fractionated
on columns of DE-52 equilibrated with SO niM tris-HCl at pH 7.2.

A

salt gradient of NaCl was used to elute the suppressor-active material.
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TABLE 4
Thermal Stability of Suppressor-Active Supernatants

X Suppression

X Suppression after heating

Untreated

80° x 10 mln

87

55

40

15

64

42

44

31
100° x 5 mln

38

0

35

0

29

0

46
TABLE 5
The Effect of Trypsin on Suppressor Activity

L

cpM0

Supernatant Humber

X Suppression

Con A Control

76,538 ± 6,199

-

Con A + Trypsin + DFP°

75,116 ± 2,038

-

1

31,967 + 3,548

56

i

77,113 ± 9,017

N^

2

43,318 + 6,522

43

2 T

65,721 ± 8,011

13

3

46,840 t 5,264

38

3 T

79,292 ± 2,664

NS

4

65,183 ± 8,991

13

4 T

76,012 ± 9,726

NS

S

40,734 ± 1,288

46

5 T

76,453 ± 2,851

NS

6

31,942 ± 3,030

58

6 T

43,627 ± 7,444

42

flCounts per minute ± standard deviation, n - 3.

X Suppression calculated using con A + trypsin + DPP control
value.
°DFP added to trypsin prior to addition of trypsin to con A control.
^Trypsin-treated supernatant.
eNot significant.
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Figure 5.

Elution profile of tonsil supernatant fluids

on Sephadex G-100.

After equilibrating the gel in .05 M

NH4HCO3 ptl 7.2* a 1.5 x 90 cm column was poured.

An aliquot

of 200 eg of the crude preparation was rehydrated in 1.5 ml
of buffer and applied to the column.

Fractions of two ml

were collected, pooled as shown and concentrated by
lyophllizatlon.

The concentrated pools were rehydrated in

RFMI-1640 and submitted to the suppressor/augmehtor assay.
Percent suppression (pools 1 and 2), percent augmentation
(pool 5), and ODjgg nm (•-- •).
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Representative data from one of several experiments are shown In Fig.

6 . They revealed that the significantly suppressive substance (Pool
6) adhered strongly to the anion exchanger and eluted In fractions of
conductivity corresponding to 0.4 M to 0.6 M NaCl.

Less than one-

fourth of the total protein (as determined by OI^q) was found In the
active fraction (Pool 6), but the activity present In this poo]
comprised about one-half of the total bloactivlty.
Five supernatants were examined for protein (OD280) a°d suppression
before and after fractionation on the anion exchanger.
activity was then determined as described.

Specific

As shown in Table 6 ,

four of the five supernatants tested had improved specific activity
after elution compared to unfractionated preparations.
actual increase in units of

The amount of

activity varied greatly with a range of

6.3 to 459.
Polyacrylamide Gel Electrophoresis of Suppressor Active Super
natant Fluids.

Polyacrylamide gel electrophoresis was performed on

the crude suppressor supernatant preparations and the hioactive
anion exchange fraction.
and pooled AB

serum.

Control proteins were human serum albumin

There was considerable protein heterogeneity

within each crude supernatant preparation.

The observed pattern (Fig.

7) was noted repeatedly in several active supernatant fluids.

There

consistently were 7 or B stalnable bands visible in each gel.
Electrophoresis of the anion exchange fraction (Pool 6) revealed
a single band lightly stained with Coomassle Blue.

The protein

migrated slightly faster than human serum albumin in a control gel.
Its mobility corresponded to that of a protein present in the
unfractionated supernatant.
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Figure 6 .

Ion exchange (DE-52) chromatography of a

suppressor active tonsil supernatant.
in with SO ram tris-HCl pH 8.2.

The gel was equilibrated

100 pg of lyophillzed

supernatant preparation was applied to the column and
eluted with a linear salt (NaCl) gradient of 0 to 1 M.
Fractions of 2.0 ml were collected and prepared for bloassay
as described.
O.D .220 nm

Fractions were pooled as shown by shaded areas.
’ conductivity (mMHO's » —

is percent suppression in bloassay.

), shaded area
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TABLE 6
Specific Activities of Unfractionated and Fractionated Suppressor Supernatants

Unfractionated Supernatant
OD280a

Percent Suppression^*

Specific
Activity*1

OD280a

Ion Exchange Fraction 6

Specific

Percent Suppression

Activity

1.79

21

12

.604

24

40

1.43

38

27

.608

20

33

1.43

44

31

.588

15

26

0.409

16

39

.186

30

161

0.117

58

496

.073

70

959

^ 0^280 spectrophotometric measurements before and after ion-exchange fractionation.
^Percent suppression calculated as described in text.
^Specific activity calculated by:

S. A. * ? Suppression
“ 280
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Figure 7.

Polyacrylamide Gel Electrophoresis of Active
Supernatant Fluids

Polyacrylamide gel electrophoresis of pooled human AB+ serum
(A), human serum albumin (B), crude supernatant preparation (C),
and pool 6 of anion exchange fractionation (D) are shown.
Arrows Indicate lightly staining bands of Coomassie Blue.
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Gels loaded with a sample of Pool 6 were stained also with PAS
to detect glycoproteins.

The protein which took the Coomassle Blue

did not stain with PAS (data not shown).

The control proteint

ovalbumin, (20 yg) accepted the stain and was visible approximately
two thirds of way down the gel.
Isoelectric Focusing of Suppressive Supernatant Fluids.

Sup

pressor-active preparations were focused In gradients of pll 3- 10 ,
4-7, or 5-8.

The result of Isoelectric focusing through a pH gradient

of 3-10 Is shown In Fig. 8 .

Signfiicant activity focused diffusely

beginning at pH 4.4 and extending to pH 5.6.

The most active fraction

(No. 9) produced 70S suppression In the bloassay.

In several exper

iments, conducted In gradients of pH 3-10, 4-7, or 5-8, the pH range
of significant activity was 4.3-6.3, and the mean pi was 5.0 ± 0.6
(Table 7).
A control plate containing no protein was also focused (data
not shown).
experimental.

Fractions were treated In a manner Identical to the
There was no suppressor activity noted In the bloassays

of control fractions.
Chromatofocuslng of Suppressor Supernatant Fluids.

Suppressor

active supernatant preparations were fractionated on chromatofocuslng
columns using PB 74 as the eluent buffer.

Fractions of 2.0 ml were

collected and the pH of each fraction determined.
combined Into six equal pools.
column control in the bloassay.

The fractions were

The first 5 fractions served as a
In two separate experiments, there

was no demonstrable biological activity In any of the six poolB.
A control experiment was done to determine If the polybuffer
interfered with con A stimulation of PBL.

From this experiment (data
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Figure 8 .

Isoelectric Focusing of suppressor active

tonsil supernatant using Pharmalytes (range: pH 3-10).
Shaded area is percent suppression of individual fractions
and pH (a—

.

I 2 3 4 5 6 7 8 9 10 II 12 13 14 15
Fraction Number
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TABLE 7
Summary of Suppressor Isoelectric Points

b

Ampho lines*1

Range

pi of Suppression

Ampholyte

3-10

4.26, 4.55

Ampholyte

3-10

4.75, 5.16

Ampholyte

3-10

4.27

Pharmalyte

3-10

4.4, 4.6, 4.88
5.25, 5.63, 6.3

Pharmalyte

4-7

5.41

Pharmalyte

5-8

5.0

Mean pi

+

S. D. ■ 5.0

±

0.6

a Brand name of polyamino-polycarboxyllc acid.

b u
pH range.
°Isoelectrlc point of significant suppressive fractions.

£
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not shown) It was learned that the blastogenic effect of con A was
not significantly altered by the presence of nondlalyzable polybuffer
constituents.

That the suppressor was bound or Inhibited by the

polybuffer was not investigated.
Anesthesia and Its Relationship to Suppressive Activity.

Patients

about to undergo tonsillectomy were anesthetized with combinations of
the general anesthetics ethranc, nitrous oxide, and sodium pcntothnl.
To test the possibility that these drugs were related to the observed
suppression, the mean per cent suppression for supernatant fluids from
14 patients were classified according to the anesthesia used and
analyzed by one way ANOVA (Table 8),
There was no significant difference between groups and it was
concluded the anesthesia had no effect on the degree of suppression.
Mitogenlc Activity In Tonsil Supernatant Preparations.

Concen

trated crude supernatant fluids from tonsillar lymphocytes grown in
the absence of serum or any stimulatory agent were tested for their
ability to stimulate blastogenesis in allogeneic PBL.
As shown In Table 9, 13 of the 30 supernatants tested significantly
stimulated the incorporation of

3
H-thymldlne corresponding to

mitogenlc Indices from 2 to 7.2.

Fourteen supernatants had Mi's

greater than one but less than two, while four supernatants had no
significant effect.

The mean mitogenlc Index was 2.4.

As also indicated by the data

(Table 9), there was no apparent

relationship between total protein in the crude preparation, primary
culture blastogenesis and the degree of stimulation.
Augmentation In Tonsil Supernatant Fluids.

In the bloassays for

suppression, it was noted that several of the supernatant preparations
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TABLE 8
Anesthesia

b>c

Group

I

Ethrane,

Percent Suppression

Pentothal

31

11
II

Flourane, N20

11
64
40
7
13
16
83
30

III

Ethrane, H20

11
44
45
36

Anesthesia types grouped according to combination used.
Percent suppression calculated as described In text.
'F from one-way analysis of variance was 0.0239.
^F ■ 11.

No significant difference.

TABLE 9
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture

Supernatant
Number

Primary
Volume®

cpn^

Protein
Concentration®

AB*^

MF cpme

MI^

1

200

2,445 + 390

348

1,206 + 340

3,583 + 623

2.9

2

300

5,120 + 759

550

1,850 + 769

7,098 j- 119

3.8

3

300

3,029 + 668

464

1,654 + 675

6,296 * 463

5.0

4

300

9,288 + 1,415

600

1,097 + 564

7,919

7.2

5

300

5,262 ± 535

330

783 + 139

3,618 + 1,682

4.6

6

300

21,596 + 1,997

130

783 + 139

2,373

351

3.0

7

150

9,064 + 642

115

783 + 139

1,764

872

2.3

8

550

9,383 + 483

100

783 + 139

1,944

521

2.5

9

70

4,516 + 411

50

783 + 139

976 + 151

1.2

10

250

1,937 + 368

90

1,912 + 207

9,725

3,633

5.0

11

84

2,717 + 297

140

1,912 + 207

2,551

1,272

1.3

12

136

10,597 + 1,100

590

1,912 + 207

3,467

1,625

1.8

13

1000

12,430 + 1,433

580

799 + 277

712

272

KS

977

TABLE 9 (Cont)
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture

Supernatant
Number

Primary
Volumea

Protein
Concentration11

cpm

AB

MF cpme

MF

14

600

7,193 + 871

340

799 + 277

1,125 + 238

1.4

15

200

18,790 + 816

160

799 + 277

1,359 + 376

1.7

16

116

7,694 + 992

150

942 + 360

4,229

17

100

3,380 ± 323

30

942 *■ 360

18

600

7,373 + 1,188

330

942 * 360

19

830

15,016 + 1,568

1120

20

247

12,878 + 1,337

21

232

22

3,128

4.5

741

316

NS

1,103

266

1.2

360

927 + 445

320

942 £ 360

1,265 + 667

1.3

11,875 + 660

390

942 + 360

1,270

330

1.3

167

29,285 + 1,951

150

789 ± 344

23

550

14,985 + 1,755

265

789 ± 344

1,386

597

1.8

24

550

7,967 + 843

300

789 ± 344

1,070

502

1.4

25

350

420

789 ± 344

835 + 505

NS

26

200

380

567 ± 211

954 4- 754

1.7

11,629

2,277

9,993 + 499

942

670 * 225

NS

NS

TABLE 9 (Cont)
Comparison of Mitogenlc Activity with Total Protein and Non-Induced Blastogenesis of Primary Culture

Primary

Supernatant

cpn£

Protein
Concentration*7

Number

Volume*1

27

200

9,522 ± 466

400

28

200

8,260 ± 638

29

200

6,787 ± 595

,_-kf
AB

MF cpme

MI*

567 ± 211

1,178 t 174

2.0

382

567 ± 211

2,194 ± 947

3.9

460

567 ± 211

1,274 ± 663

2.2

V o l u m e of original supernatant (ml).
lj

cpm ± S. D. (n * 6) of non-induced blastogenesis in the primary culture.
CProtein concentration (fig/ml) in crude supernatant as determined by Lowry (97).
^Cpm ± S. D. (n ■ 6) of AB+ control in bioassay.
Cpm ± S. D, (n ■ 6) of mitogenlc supernatant In bloassay.
■^Mitogenlc index calculated as described In text.

u»
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had an enhancing effect on con A-induced blastogenesis.

Since augmen

tation required the presence of con A, the degre^ of enhancement (per
cent augmentation) was calculated by comparing the tested supernatant
cpm with the con A control (10 pg/ml) cpm.

Significance was determined

by taking the difference between means of test supernatant and control
and establishing 95% confidence limits about the difference.

The error

used In calculating the limits was from one way ANOVA.
Of the many supernatant fluids tested in the suppressor/augmentor
assay (Table 10), 14 caused significant Incorporation of ^H-thymidine
greater than that of con A control values.

The amount of augmentation

varied greatly ranging from 12% to 211%.
When the per cent augmentation was compared with total protein
and primary culture cpm, there was no observable relationship (Table

11).
Mitogenlc Factor and Augmenting Dose Response Curves.

In some

supernatants it was possible to observe both mitogenlc and augmenting
activities.

Four of these supernatants were examined for dose

responsiveness based on total protein In the crude preparation.

Serial

dilutions of the supernatants were made and subjected to the MF and
suppressor/augmentor assays.

Representative dose curves of a doubly

active supernatant are shown in Figures 9 and 10.

The mitogenlc

activity (Fig. 9) behaved in a dose dependent fashion and seemed to
approach a plateau of saturation at higher concentrations.
The slope of the dose response curve for augmentation (Fig. 10)
was quite different from the dose curve obtained from MF.

There was

no apparent increase In cpm as a function of Increasing dosages.
However, linear regression analysis revealed that the MF and augments-

TABLE 10
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal FBL Stimulated with Con A°

Experiment

Sample

Number

Number

1

7}

Con AC

1

2

A

5

g
Augmentation

107,547 ± 5,995
50,489 + 12,085

Con A

79,793 ± 14,494

Con A

^
A Keatr

q

Significant"

34,577 ± 8,875

2

3
3

d

cpm

112,023 ± 3,852

2112

+72,970 ± 13,135

+

462

+15,912 ± 13,135

+

402

+32,230 ± 16,696

+

162

+16,373 ± 14,583

+

252

+22,090 ± 6,407

+

99,711 ± 6,674

4

116,084 ± 5,541

Con A

88,953 ±1,631

5

111,043 ± 6,845

Con A

69,331 ± 4,390

6

114,165 ± 23,763

652

+44,834 ± 25,398

+

7

108,589

572

+39,259 r 25,398

+

20,744

TABLE 10 (font)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal FBL Stimulated with Con A

Experiment
Number

6

7

8

9

10

Sample
Number^

cpm*

Augmentation6

A Mean/"

Significant^

8

123,197 ± 14,310

782

+53,866 + 25,398

+

9

115,865 ± 14,184

672

+46,534 ± 25,398

+

Con AC

72,716 + 8,683
242

+17,737 ± 14,167

+

302

+18,810 ± 10,484

+

282

+18,372 ± 8,530

+

392

+28,033 ± 8,890

+

122

+ 7,469 ± 6,689

+

10

90,453 ± 10,794

Con A

62,972 + 8,403

11

81,782 + 7,183

Con A

64,986 ± 4,142

12

83,359 ± 3,529

Con A

71,770 ± 1,013

13

99,804 ± 3,451

Con A

63,022 ± 3,151

14

70,492 ± 1,687

TABLE 10 (Cont)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal PBL Stimulated with Con Aa

Experiment

Sample

Number

Number^

11

Con AC

12

13

cpra^

80,663 ± 10,336

Con A

56,714 ± 2,673

16

62,609 ± 7,701

17

65,966 ± 9,588

18

A Mean*

Significant^

73,984 ± 3,537

15

Con A

g
Augmentation

+ 6,679 ± 9,945

+

10%

+ 5,859 ± 10,272

-

16%

+9,252 ± 10,272

-

11%

+ 8,441 ± 16,696

-

92

79,793 ± 14,494
88,234 ± 3,519

cTonsil cells were cultured in the absence of stimulation.

The supernatants were assayed by their

effect e on FBL cultured in the presence of Con A.

b
Numerals refer to individual patients' tonsils.
Con A refers to radioactivity incorporated by PBL stimulated with Con A in the absence of tonsil
cell culture fluid.

TABLE 10 (Cont)
Effect of Tonsil Cell Culture Fluids on Transformation (Augmentation)
of Normal PBL Stimulated with Con A

Mean cpm ± S. D. (n = 6).
Percent augmentation of radioactivity incorporated by PBL stimulated with Con A in the presence of
tonsil cell culture fluid compared to that incorporated In the absence of tonsil cell culture fluids as
described in text.
J The difference between means of test supernatant and control ± 95% confidence limits about the
difference.
“ The error used to calculate limits was from analysis of variance.
(+) indicates significant augmentation.

TABLE 11
Comparison of Augmentation with Total Protein and Non-Induced
Blastogenesis of Primary Culture

Primary Culture Parameters
Protein Concentration
(lig/ml)a

Volume
(ml)^

Blastogenesis
(cpm)c

Bloassay of Primary Culture
Percent Augmentation

1

348

200

2,445 ± 390

30

2

550

300

5,120 ± 759

29

3

464

300

3,029 ± 668

33

4

600

300

9,288 ± 1,415

12

5

140

84

2,717 ± 297

40

6

590

136

10,597 ± 1,100

11

7

160

200

18,790 ± 816

18

8

150

116

7,694 ± 992

2

9

30

100

3,380 ± 323

7

10

1120

830

15,016 ± 1,568

7

11

320

247

12,878± 1,387

13

TABLE 11 (Cent)
Comparison of Augmentation with Total Protein and Non-Induced
Blastogenesis of Primary Culture

Primary Culture Parameters
Supernatant

Protein Concentration

Number

(yg/ml)a

Volume
(ml)*

Bias togenesls

Bioassay of Primary Culture

(cpm)C

Percent Augmentation

12

390

232

11,875 ± 660

16

13

382

200

8,260 ± 638

7

14

460

200

6,787 ± 595

7

Q Protein concentration (vg/ml) in primary culture supernatant preparation as determined by
Lowry technique (97).
£
Volume of original supernatant fluid (ml).
Cpm ± S. N. (n • 6) of non-induced blastogenesis of primary culture.

d

Percent suppression in bioassay of primary supernatant culture fluids.
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Figure 9.

Serial dilutions of concentrated MF active

supernatant fluids.
of total protein.

Activity expressed in cpm as a function

8000700060005000*
4000*
30002000

•

1000-
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Figure 10.

Serial dilutions of concentrated augmenting

active supernatant fluids.

Activity expressed as percent

augmentation as a function of total protein.

Percent Augmentation
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tion dose curves were more complex than straight lines (data not
shown) and peak points of both curves were significant based on
Dunnett's test.
Molecular Sieve Chromatography of Supernatant Fluids with
Suppressor and Augroentor Activities.

In experiments to determine the

suppressor, it was possible to detect both suppressive and augmenting
activities In a single supernatant preparation.
Fractionation on Sephadex G-100 of suppressor-active supernatant
fluids (Fig. 5) repeatedly demonstrated one pool to contain the
augmenting effect.

The active fractions corresponded to the elution

volume of carbonic anhydrase and, therefore, its apparent molecular
weight was about 30,000,
Anion Exchange Chromatography of Augmenting Supernatant Fluids.
Anion exchange chromatography of both suppressive and augmenting
supernatant preparations was performed using a sodium chloride gradient
of 0 to 1 M.

Fractions of 1.0 ml were collected.

The protein

(OD220) content and conductivity of each fraction was determined, and
then they were pooled as shown In Figure 11.

The pools were prepared

for the suppressor/augmentor assay In the usual manner and subsequently
tested for augmenting activity.
In moBt experiments, augmentation was expressed In the 0.15 to
0.25 M Balt fractions regardless of the activity (i.e. suppression or
augmentation observed in the assay of the crude preparation.)
Augmenting activity corresponded to the minor optical density peak of
the biphaslc curve.
On one occasion, augmenting activity was noted In the 0.38 M
salt fractions.

There was, however, no detectable absorbance at
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Figure 11.

Anion exchange chromatography of augmenting

active supernatant fluid.
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0^220

t^iese fractions.

Determination of Augmentor Producing Cell Population.

To deter

mine the cellular origin of augmenting activity, tonsillar cells were
separated on the basis of their adherence properties.
Although culture controls (Table 12) demonstrated significant
augmentation with respect to con A control values, Dunnett's test
(data not shown) Indicated there was no significant difference in the
amount of augmentation observed in the culture controls and the
adherent or non-adherent qualities of the cell population.
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TABLE 12
Adherent Cel 1 Study For Augment inf;

2

3

4

CPN^

Con A

72,716 J 8,683

Control^

75,296 i 8,146

Adherent'

81,927

Non-Adherent

76,533 ± 5,654

Con A

72,716 + 8,683

Control

92,767 ± 10,797

Adherent
Non-Adherent

93,675 ± 10,586

Con A

37,829 ± 2,634

Control

45,639 ± 3,966

Adherent

37,735 ± 2,726

Non-Adherent

46,146 ± 4,499

Con A

74,804 + 8,350

Control

80,776 + 6,663

Adherent

79,454 ± 12,863

Non-Adherent

83,758 + 9,115

Con A

56,714 + 2,674

Control

70,613 ± 5,875

Adherent

74,607 ± 11,265

Non-Adherent

67,194 ± 9,619

o

1

Culture

OS
o

Experiment

6,216

± 7,166
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Adherent Cell Study for Augmenting

Experiment

6

Culture

CPM0

Con A

59,485 l 5,439

Control^

47,905 ± 7,760

Adherent0

47,080 ± 8,817

Non-Adherent

57,184 ± 6,010

aCpm ± S. D. (n ■ 6)
1Control cultures essayed

sb

usual

^Adherent cell population allowed to adhere to tissue flask for
2 hr, then the non-adherent cells was decanted.
rehydrated to the same volume.

The adhered cells were

All cultures were Incubated for 24 hr.

CHAPTER 4
DISCUSSION
Transformation and prollforation of small lymphocytes in viLrvj
follows activation by antigens or by various mitogens.

Among the

consequences of activation is that both T and B lymphocytes secrete
certain products called lymphoklnes (102)* and a rather large number
of bloactlvltles have been attributed to these soluble mediators of
Immune response.

In vitro, lymphoklnes cause phenomena which mimic

type IV tissue reactions* and more recent perceptions are that some
of these functions immunoregulatory,

It is widely presumed that

lymphoklnes also are produced in vivo by lymphocytes activated by
natural antigens.
Tonsils are lymphatic organs which comprise similar percentages
of T and B lymphocytes (103, 104); and very low percentages of mono
cytes (104).

Their cells produce the lymphoklnes lymphotoxln (102),

colony stimulating factor (106), T cell growth factor (54), and at least
one suppressor factor (65) subsequent to in vitro activation.

Since

the proliferative response of tonsil cells in some humans is apparently
evident by frequent episodes of tissue swelling, it is likely that
tonsil cells would be engaged in Immunoregulatory activities.

During

the subsiding phase, it seems possible that suppression of cellular
proliferation might be induced by a soluble mediator.
A major problem Inherent in the isolation and purification of
most lymphoklnes has been the lack of substantial quantities of
starting material for biochemical analysis.

For this reason, it was

thought that tonsils would provide a large and readily available
source of lymphokine producing cells.
The cell culture methodology for both the primary tonsillar
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lymphocyte cultures and the bioassays had been well established in
the literature and was adapted to these experiments with modifica
tions,

Unique to this study was the absence of serum during the

primary culture, the use of Ficoll-Panue to Isolate the mononuclear
fraction of the tonBillar tissue, and the absence of in vitro
stimulation of the primary culture.
Normally, lymphocytes grown in primary culture for any length of
time required at least 10% serum.

However, it was found that the

lack of serum in our cultures for 24 hr did not cause significant loss
of viability.

Furthermore, growth of these cells in media free from

exogenous serum contaminants facilitated purification of
endogenous protein.
Bouyant density flotation on Ficoll-Faque had been used routinely
to Isolate mononuclear cellB from whole blood but rarely from tonsillar
tissue.
reasons.

The use of Ficoll-Paque was chosen for these studies for two
First, separation by Ficoll-Panue eliminated unwanted

tonsillar cell types whose
bioassay.

products may have interferred with the

Secondly, it was generally accepted that all three mono

nuclear cell types i.e. T cells, B cells, and monocytes were required
for the production of most lymphoklnes (107) and Ficoll-Paque effecti
vely separated these cells (95% mononuclear cells) from other tonBil cells
and debris, and Improved the yield of viable mononuclear cells.
Preliminary experiments in which con A was Incubated with the
tonsillar lymphocytes and then subsequently removed by adsorption to
Sephadex, revealed that supernatant fluids of cultures incubated with
con A caused less

H-thymldine Incorporation in the bioassay than did

control cultures.

This result was reasoned to he indicative of a

suppressive substance present in the supernatant preparation.
Tonsil lymphocytes were shown to be synthesizing DNA in the
absence of in vitro stimulation. The extent of incorporation of
3
H-thytnidine by these cells varied from a few thousand to greater
than ten thousand cpm at the time of measurement.

These data

confirmed those of Drucker et al. (108) who termed the phenomenon
"preactivation11.

Similar observations were made by Williams and

Korsmeyer (109) in studies with human cord blood lymphocytes.
In these experiments, tonsil lymphocytes activated in vivo
presumably as a consequence of naturally occurring antigen Insult
secreted suppressive material which significantly inhibited the
expected response of PBL to con A.

This was in agreement with the

work of Wolf et al. (65) who suggested that tonsil T lymphocytes
elaborated a substance which suppressed the response of PBL to
phytohemagglutinin and certain antigens.
The rather wide range of suppression percentages reported
here probably were at least partially attributable to the genetic
variability between the tonsillar cells and the donor target cells
for the bloassay.

To circumvent this problem, many different

supernatant fluids were tested in a single assay as lagistlcally
as possible.

Ideally,

lymphocytes from a single individual would

have caused less heterogeneity with respect to suppression but this
could not have been accomplished readily.
After the initial discovery of the suppressive activity,
Btudles were undertaken to determine the relationship, between the
degree of non-lnduced proliferation of the primary cultures,
total protein in the crude preparations and the percent suppression
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In the bioassay.
Intuitively, one might predict that an Increase In total protein
would be accompanied by an increase in percent suppression as well as
an increase in non-induced blastogenesls of the primary culture.
Similarly, one would expect a concomitant Increase in percent suppres
sion and non-induced blastogenesls.

However, data accumulated from

several experiments indicated there was no correlative Increase or
decrease in suppression as a function of any of the measured
parameters.
The active substance apparently was protein since trypsin
treatment of the crude preparation destroyed the suppressive effect
in nearly all supernatant fluids tested.

However, one supernatant

preparation with a relatively high OD250 value, was still suppressive
after enzyme treatment.

This might have been due to the reported

suppression of mitogen stimulation by nucleic acids (66).
The apparent molecular weight of the suppressor factor, as
determined by molecular sieve chromatography, was >100,000.

Attempts

to further define the molecular weight by sieving through Sephadex
G-200 and Bio Gel P-150 resulted in loss of biological activity.
Tlbbets et al. (91) described a suppressor which inhibited PHA
stimulation of lymphoid cells.

The factor was produced by mitogen-

stimulated PBL and had an apparent molecular weight of >100,000 d.
The suppressor identified by Volf et al. (65) was also in excess

0? 100,000 d.
The suppressor material adhered strongly to the anion exchanger
DEAE, eluting in the 0.4 M-0.6 M salt fraction.

This step in puri

fication gave only a slight increase in specific activity. Folyacryl-
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amide gel electrophoresis showed more homogeneity of the anion
exchange fraction with respect to the crude, concentrated prepara
tion in that the active fraction contained one lightly staining
band, while 7-8 bands were detected in the crude preparation.

The

gels, although loaded with concentrated partially purified suppressor,
were not inbued to the extent that homogeneity was confirmed.
The rather diffuse range of isoelectric points reported here for
the suppressor activity may belle charge heterogeneity.

This heteroge

neity was evidently not due to sugar residues since PAS staining (sen
sitive to 5 pg) detected no glycoproteins for the concentrated, crude prep
aration nor the active anion exchange fraction.

Loss of amide groups,

cycllzatlon of pyrollldone groups or non-specific aggregation of
the suppressor with de novo protein in the primary culture mav
account for the variation in charge.
The fact that the suppressor material was nondialy2able suggested
that the activity was not attributable to thymidine secreted by
monocyteB during generation of the supernatants (110), or to prosta
glandins E, or

The suppressor from the preactivated tonsil cells

was not the normal immunosuppressive protein described by others (7A, 75)
and it was not some other serum-derived factor because neither plasma
nor serum was present (72, 73, 76); nor was suppression due to comple
ment components since heating at 56° C for 30 mln, which inactivates
complement, had no effect on suppression.

It was not likely that the

suppressor was.a 1bacterial -product such as endotoxin (111) or a fungal
product elaborated during culture because prior to culture the tonsils
or tonsil cells were kept in*media

which was*heavily fortified with

antibacterial and antifungal chemicals.. The culture medium was
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fortified also, and the cultures were aBceptic at harvest.

The sup

pressor apparently was not immunoglobulin fi, A, H, or E or a2macroglobulin.

It did not seem likely that u^-acld glycoprotein,

which inhibited the response of lymphocytes to con A (77), could
have been transferred on tonsil tissue in a quantity sufficient to
be Inhibitory in our experiments.
The binding site of con A has been shown to be specific for
a-D-manopyranose, a-D-glucopyranose or sterically similar residues
(29) and, consequently, is specifically Inhibited by methyl-a-D
manopyranose.

The active fraction obtained from anion exchange

chromatography, however, did not comprise any stalnable glycoproteins
and it was concluded that the suppression did not occur by nonspeci
fic binding of con A to sugar moieties.
The viability of target cells consistently was 90% or greater.
Thus the suppressive agent did not act by causing extensive death
of target lymphocytes.

The suppressor was not lymphotoxln since

this lymphoklne did not act on human lymphocytes.
It was suggested in the literature that certain general anestherics (112, 113, 114) suppress the immune response by acting on
lymphocytes.
transient,

Rats Injected with 1.5% halothane developed

a

reduced capacity to induce lysis of antibody-coated

target cells compared with those from untreated animals.

The

result reported here Indicated statistically that suppression
occurred irregardless of

the

type of anesthesia

used.
In most supernatant culture fluids, suppression was the predomi
nant biological activity observed.

Occasionally, however, cultures
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comprised material which enhanced the expected activation of PHI. hy
con A,

Augmentation was also present in suppreBsor supernatant pre

parations.

Evidently, the suppressor masked

the augmenting

activity until separation of the two molecules was effected on
G-100 or anion exchange chromatography columns.
It was possible that the enhancing effect was due to T cell
growth factor since this lymphokine has been shown to augment the
effect of mitogens (62).

Warren et al. (66) previously reported that

tonsillar T lymphocytes were capable of producing a T cell growth
factor like substance which promoted the growth of lymphocytes in
long term culture.
T cell growth factor has been shown to elute from anion exchange
columns in 0.07M NaCl and to have an apparent molecular weight of
15,000.

In these experiments, however, the augmentor was eluted

from the ion exchanger in 0.15-0.25 M NaCl and was shown to be 30,000
in molecular weight.

These discrepancies may possibly be accounted

for by the aggregation of endogenous protein which has been shown to
occur in cell cultures grown without serum (115).
Since T cell growth factor is produced by the non-adherent T
lymphocyte, studies were undertaken to separate the tonsillar lympho
cytes Into adherent and non-adherent populations.

No definitive conclu

sion could be drawn from these experiments presumably due to the Inability
to adequately separate the two populations in the absence of serum.
In nearly all unstimulated tonsil lymphocyte supernatant fluids
tested, there was at least minimal mitogenic activity present.

Mlto-

genlc factor apparently was different from the augmentor since (a) the
mitogenic activity did not rumiire lectin

co-wtlimitation for the
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expression of biological activity, (b) MF activity was dcmopstreble In
the presence of the suppressor, while the augmentor was not, and (c)
the dose response curves for the two activities, which were derived
from the same supernatant fluids, were different shapes.
Some lymphokines are presumed to have an immunoregulatory role.
The suppressor, augmentor, and mitogenic factor described here may
function to regulate cellular proliferation..

It is not yet certain

that they act in a biologically relevant manner.

They do inhibit

or augment the proliferative response to a plant lectin or, as is
the case with mitogenic factor, act independently of mitogen-stimulated
blastogenesls; but these are experimental phenomena engineered in

vitro.

The mechanism of suppression, augmentation, and mitogenic

activity Is not understood.

However, the action of these molecules

In the presence of one another in vitro may provide clues as to their

in vivo functions.
In summary, our initial objectives were achieved In so much as we
demonstrated the existence of three soluble factors produced by tonsil
mononuclear cells which had different affectations on PBL prolifera
tion.

Furthermore, isolation and partial characterization of the

suppressor factor was facilitated since there were no serum factors
contaminating the primary cultures.

Alternatively, we did not tonflrm

lmmunoregulatory properties I.e. the relationship, between the three
factors in vitro or in vivo.
These experiments have raised several questions which, If answered,
would add to our understanding of how the immune system functions.

For

example, how can MF and the suppressor be present In the same superna
tant; Is It produced by the same or different cell types?

Secondly,
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does Che suppressor Inhibit the augmentor stolchloraetrlcally?

This

could be determined only by first separating the two entitles then
adding them back to each other In titrating doses.

Thirdly, haw does

the suppressor function mechanistically, i.e. does it directly affect
con A target cells or does it turn on suppressor cells which then
Inhibit the proliferation of con A responsive cells?

j

In light of these questions, the immediate direction of this
research seems evident.

Initially, the anion exchange fraction

containing suppressor activity should be submitted to PAGE and stained
with silver stain.

This would help determine purity since the silver

stain is more sensitive than the Coomassle stain.

Next, the same

anion exchange fraction should be examined for trypsin sensitivity to
eliminate the possibility of suppression by nucleic adds.

Assuming

these experiments yield the expected results, the anion exchange
fraction could then be applied to generating rabbit anti-suppressor
antibodies.

Suppressor specific antisera would greatly facilitate

further purification of the factor as well as help answer the immunoregulatory questions presented above.

if
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